In vitro activity of gemifloxacin against Streptococcus pneumoniae isolates in Germany

被引:4
作者
Lemmen, S [1 ]
Al-Lahham, A [1 ]
Lütticken, R [1 ]
Reinert, RR [1 ]
机构
[1] Rhein Westfal TH Aachen, Univ Hosp, Inst Med Microbiol, Natl Reference Ctr Streptococci, D-52057 Aachen, Germany
关键词
pneumococci; Streptococcus pneumoniae; gemifloxacin; in vitro activity; Germany;
D O I
10.1159/000048508
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The MICs (minimal inhibitory concentrations) of gemifloxacin, moxifloxacin, ofloxacin, ciprofloxacin, levofloxacin, sparfloxacin, penicillin G, tetracycline and erythromycin were determined for 200 clinical pneumococcal isolates using the microbroth dilution method. MIC50 and MIC90 values were as follows (mg/l): 0.016 and 0.016 (gemifloxacin, penicillin-intermediate strains), 0.03 and 0.06 (gemifloxacin, penicillin-susceptible strains); 0.125-0.5 and 0.25 (moxifloxcacin); 1-2 and 4 (ciprofloxacin and ofloxacin); 1 and 2 (levofloxacin), and 0.25-0.5 and 0.5 (sparfloxacin). MIC50 and MIC90 values for the fluoroquinolones were nearly identical for individual antimicrobial agents in the penicillin-susceptible and penicillin-intermediate groups of strains. Erythromycin and tetracycline were less active against penicillin-intermediate pneumococci isolates (erythromycin: MIC90 8 mg/l; MIC range 0.06-greater than or equal to 64 mg/l; tetracycline: MIC90 greater than or equal to 64 mg/l, MIC range 0.25- greater than or equal to 64 mg/l) as compared to penicillin-susceptible isolates (erythromycin: MIC90 0.5 mg/l, MIC range 0.06-greater than or equal to 64 mg/l; tetracycline: MIC90 8 mg/l, MIC range 0.06-greater than or equal to 64 mg/l). Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:104 / 109
页数:6
相关论文
共 21 条
[1]   Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada [J].
Chen, DK ;
McGeer, A ;
de Azavedo, JC ;
Low, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (04) :233-239
[2]   Antimicrobial activity and spectrum of LB20304, a novel fluoronaphthyridone [J].
Cormican, MG ;
Jones, RN .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (01) :204-211
[3]   Antipneumococcal activities of gemifloxacin compared to those of nine other agents [J].
Davies, TA ;
Kelly, LM ;
Pankuch, GA ;
Credito, KL ;
Jacobs, MR ;
Appelbaum, PC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) :304-310
[4]   Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens - Findings of the Alexander Project 1992-1996 [J].
Felmingham, D ;
Washington, J .
JOURNAL OF CHEMOTHERAPY, 1999, 11 :5-21
[5]   Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain:: Update (1990 to 1996) [J].
Fenoll, A ;
Jado, I ;
Vicioso, D ;
Pérez, A ;
Casal, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (12) :3447-3454
[6]   In vitro activity of gemifloxacin (SB 265805) against anaerobes [J].
Goldstein, EJC ;
Citron, DM ;
Warren, Y ;
Tyrrell, K ;
Merriam, CV .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (09) :2231-2235
[7]   In vitro activity of gemifloxacin (SB 265805; LB20304a) against human mycoplasmas [J].
Hannan, PCT ;
Woodnutt, G .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (03) :367-369
[8]   Comparative in vitro activities of ciprofloxacin, gemifloxacin, grepafloxacin, moxifloxacin, ofloxacin, sparfloxacin, trovafloxacin, and other antimicrobial agents against bloodstream isolates of gram-positive cocci [J].
Hardy, D ;
Amsterdam, D ;
Mandell, LA ;
Rotstein, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (03) :802-805
[9]   Activity of gemifloxacin against penicillin- and ciprofloxacin-resistant Streptococcus pneumoniae displaying topoisomerase- and efflux-mediated resistance mechanisms [J].
Heaton, VJ ;
Goldsmith, CE ;
Ambler, JE ;
Fisher, LM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (12) :2998-3000
[10]   Anti-streptococcal activity of SB-265805 (LB20304), a novel fluoronaphthyridone, compared with five other compounds, including quality control guidelines [J].
Johnson, DM ;
Jones, RN ;
Erwin, ME .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 33 (02) :87-91